Literature DB >> 19231395

Role of tumor necrosis factor receptor 1 in sex differences of stem cell mediated cardioprotection.

Courtney N Zeller1, Yue Wang, Troy A Markel, Brent Weil, Aaron Abarbanell, Jeremy L Herrmann, Megan L Kelly, Arthur Coffey, Daniel R Meldrum.   

Abstract

BACKGROUND: Mesenchymal stem cells (MSCs) hold great therapeutic potential for the repair and regeneration of ischemic tissue, possibly through the release of beneficial paracrine factors. Sex differences have been observed in the paracrine function of MSCs. Female stem cells produce lower proinflammatory cytokines and higher levels of growth factors compared with their male counterparts. Ablation of tumor necrosis factor receptor 1 (TNFR1) increases protective growth factor production by male, but not by female, MSCs. We therefore hypothesized the following: (1) that female MSCs would improve myocardial recovery compared with male MSCs after ischemia-reperfusion injury (I/R); and (2) that MSCs isolated from TNFR1 knock out male, but not female, mice, would improve postischemic myocardial recovery compared with their wild type (WT) counterparts.
METHODS: Male adult Sprague-Dawley rat hearts were subjected to I/R by Langendorff isolated heart preparation. The MSCs were harvested from adult mice and cultured under normal conditions. Immediately prior to ischemia, one million MSCs were infused into the coronary circulation. Cardiac functional parameters were recorded continuously.
RESULTS: Pretreatment with MSCs from either sex significantly increased postischemic myocardial recovery as evidenced by improved left ventricular developed pressure, contractility, and rate of relaxation. Infusion with female MSCs was associated with a greater degree of myocardial recovery after I/R compared with male MSCs. The TNFR1 deficiency increased the degree of myocardial recovery associated with male MSCs, but not with female MSCs. No additional cardioprotection was observed when TNFR1 was ablated in female MSCs.
CONCLUSION: Sex differences influence the cardioprotective effects of both WT and TNFR1 ablated MSCs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19231395     DOI: 10.1016/j.athoracsur.2008.12.033

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  11 in total

Review 1.  Genetic engineering of mesenchymal stem cells and its application in human disease therapy.

Authors:  Conrad P Hodgkinson; José A Gomez; Maria Mirotsou; Victor J Dzau
Journal:  Hum Gene Ther       Date:  2010-10-22       Impact factor: 5.695

2.  Toll-like receptor 2 mediates mesenchymal stem cell-associated myocardial recovery and VEGF production following acute ischemia-reperfusion injury.

Authors:  Aaron M Abarbanell; Yue Wang; Jeremy L Herrmann; Brent R Weil; Jeffrey A Poynter; Mariuxi C Manukyan; Daniel R Meldrum
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-02-19       Impact factor: 4.733

3.  Tumor Necrosis Factor α Regulates Endothelial Progenitor Cell Migration via CADM1 and NF-kB.

Authors:  Anthony R Prisco; Brian R Hoffmann; Catherine C Kaczorowski; Chris McDermott-Roe; Timothy J Stodola; Eric C Exner; Andrew S Greene
Journal:  Stem Cells       Date:  2016-03-04       Impact factor: 6.277

4.  Female stem cells are superior to males in preserving myocardial function following endotoxemia.

Authors:  Mariuxi C Manukyan; Brent R Weil; Yue Wang; Aaron M Abarbanell; Jeremy L Herrmann; Jeffrey A Poynter; Benjamin D Brewster; Daniel R Meldrum
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-03-30       Impact factor: 3.619

5.  Cellular mechanisms of injury after major trauma.

Authors:  I H Chaudry; K I Bland
Journal:  Br J Surg       Date:  2009-10       Impact factor: 6.939

6.  TLR4 inhibits mesenchymal stem cell (MSC) STAT3 activation and thereby exerts deleterious effects on MSC-mediated cardioprotection.

Authors:  Yue Wang; Aaron M Abarbanell; Jeremy L Herrmann; Brent R Weil; Mariuxi C Manukyan; Jeffrey A Poynter; Daniel R Meldrum
Journal:  PLoS One       Date:  2010-12-03       Impact factor: 3.240

7.  Sex-Specific Transcriptome Differences in Human Adipose Mesenchymal Stem Cells.

Authors:  Eva Bianconi; Raffaella Casadei; Flavia Frabetti; Carlo Ventura; Federica Facchin; Silvia Canaider
Journal:  Genes (Basel)       Date:  2020-08-08       Impact factor: 4.096

Review 8.  From the Basis of Epimorphic Regeneration to Enhanced Regenerative Therapies.

Authors:  Béryl Laplace-Builhé; Sarah Bahraoui; Christian Jorgensen; Farida Djouad
Journal:  Front Cell Dev Biol       Date:  2021-01-21

9.  Sex Differences of Human Cardiac Progenitor Cells in the Biological Response to TNF-α Treatment.

Authors:  Elisabetta Straface; Lucrezia Gambardella; Francesca Pagano; Francesco Angelini; Barbara Ascione; Rosa Vona; Elena De Falco; Elena Cavarretta; Raffaele La Russa; Walter Malorni; Giacomo Frati; Isotta Chimenti
Journal:  Stem Cells Int       Date:  2017-09-17       Impact factor: 5.443

Review 10.  Critical Role of Tumor Necrosis Factor Signaling in Mesenchymal Stem Cell-Based Therapy for Autoimmune and Inflammatory Diseases.

Authors:  Li Yan; Dejin Zheng; Ren-He Xu
Journal:  Front Immunol       Date:  2018-07-20       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.